Metallothionein (MT) is a low molecular mass protein inducible by heavy metals such as cadmium (Cd), zinc, and copper, and having high affiity for these metals. In the present study, we investigated the immunohistological localization of MT in the brains of rats and mice. In adult rat brain, almost no MT immunostaining was observed, whereas in adult mouse brain strong MT immunostaining was found in the ependymal cells, some glial cells, arachnoid, and pia mater. No immunostahhg was detected in neurons and endothelial cells. In younger rats (1-3 weeks old), strong MT immunostaining was observed in ependymal cells, choroid plexus epithelium, arachnoid, and pia mater. The overall MT concentration in adult mouse brain appeared higher than that of the brains of young and adult rats. When adult rats
Introduction
Metallothionein (MT) comprises a group of metal-binding, IGW molecular weight proteins unique in properties such as inducibility on exposure to heavy metals [e.g., cadmium (Cd), zinc (Zn)], high (approximately 30% w/w) cysteine content, and heat stability. Since MT reduces the toxicity of heavy metals such as Cd and mercury ions by binding them, it is considered to have a role in detoxification of these heavy metals. Because MT exists in various tissues under physiological conditions and can be induced by various stresses and hormones, MT also is considered to have a physiological role in the transport and storage of Zn and copper ions (for reviews see Bremner, 1987; Kiigi and Nordberg, 1979; Webb, 1979) . The earlier observation that the liver and kidney from fetal and neonatal rats harbor relatively greater amounts of MT suggests that MT may be involved in physiologically fundamental roles such as growth (Nishimura et al., 1989b; Panemangalore et al., 1983 ).
An earlier autoradiographic study revealed that radiolabeled Cd is taken up relatively easily by hypothalamus, pia mater, and choroid To whom correspondence should be addressed. were administered Cd, MT was induced not only in some glial cells, ependymal cells, arachnoid, and pia mater but also in endothelial cells. Although Cd treatment resulted in an inaease in the MT immunostaining in the specific cells described above, the MT induction was not great enough to significantly affect the overall MT level in the brain. The present result suggests a possible link of MT with cell growth of choroid plexus epithelium and ependymal cells, as well as a detoxifjkg role of MT in the blood-brain barrier and the cerebrospinal fluid-brain barrier. ( J Ilistochem Cytochem 40:309-315, 1992) KEY WORDS: Avidin-biotin-peroxidase complex method Brain; Immunohistochemical localization of medothionein; Mouse; Rat; Cadmium; Blood-brain barrier.
plexus, but not by the parenchymal cells (Berlin and Ullberg, 1963a) , and it was shown that the rat brain harbors a protein very similar in physicochemical properties to other mammalian MTi (Ebadi and Babin, 1989) . Although immunohistological studies have been carried out to demonstrate localization of MT in various tissues (Nishimura et al., ,1990a (Nishimura et al., ,1989a Hazelhoff-Roelfiema et al., 1989; Savino et al., 1984) , the distribution of MT in the brain under physiological conditions and the changes of MT localization in the brain after Cd administration have yet to be clarified. In the present study, immunohistological localization of MT in the brain from control and Cd-treated rats and mice was investigated.
Materials and Methods
Reagents. Goat normal serum (Cat. No. S-1000). biotinylated goat antirabbit IgG (Cat. No. BA-lOOO), and the avidin-biotin-peroxidase complex (ABC) kit were purchased from Vector Laboratories (Burlingame, CA). Other reagents were of analytical grade.
Immunohistochemical Staining. Male rats (8 weeks old), pregnant rats of Wistar strain and male mice (7 weeks old), and pregnant mice of ddY strain were purchased from Shizuoka Laboratory Animal Center (Shizuoka, Japan). Litters of newborn rats and mice were maintained and used at 1 to 3 weeks of age.
All tissues were fixed in 10% buffered formalin and embedded in par-&in. Deparaffinized S-pm thick tissue sections were subjected to immunohistochemical staining with the ABC method as described previously (Nishimura et al., 1989a : Tohyama et al., 1988 . The immunohistochemical control test was conducted by replacing the rabbit antiserum produced against rat MT-1 with pre-immune rabbit serum and by rabbit antiserum that had been pre-absorbed with rat MT-2. The immunohistochemical control test is described in detail in earlier reports Tohyama et al., 1988) . Counterstaining with hematoxylin was done on other tissue sections after immunostaining.
To study the possible induction of MT in the brain, 8-week-old rats and 7-week-old mice were injected subcutaneously with CdClz at a daily dose of 0.5 mg Cdlkg body weight for 4 consecutive days and were then sacrificed by exsanguination under sodium pentobarbital anesthesia 48 hr after the final injection. Control rats and mice received physiological saline Metallothionein. Zinc, and Cadmium Concentrations in the Brain. Concentrations of MT in the whole brain were determined by an MT radioimmunoassay as described earlier (Nishimura et al.. 1989a; Tohyama et al., 1988) . Tissue zinc and cadmium concentrations were determined by flame atomic absorption spectrometry (Hitachi model 180-80) after digesting samples with nitric acid (Tohyama and Shaikh, 1981) . Statistical analysis for differences of mean between groups was accomplished by Duncan's multiplerange test.
Results

Immunohistochemical Localization of Metallothionein
Metallothionein Localization in Adult Rat Brain. Almost no MT was detected in the brain of saline-treated control rats ( Figure  1 ). No MT immunostaining was observed with pre-immune serum (not shown).
Metallothionein Localization in Mouse Brain. The application of pre-immune rabbit serum did not result in specific immunostaining in the mouse brain (Figure 2a ). In adult mouse brain, strong MT immunostaining was observed in the ependymal cells (cytoplasm and nucleus) of the lateral, third, and fourth ventricles and the central canal of the spinal cord (Figures 2b and 2c ). Pia mater and arachnoid also exhibited MT immunostaining (not shown). Glial cells displaying MT immunostaining in the cytoplasm, nucleus, and processes were scattered in the parenchyma (Figure 2d ). MT immunostaining was not observed in neurons and endothelial cells ( Figure 2d ) or in the hippocampus and choroid plexus (not shown).
Metallothionein Localization in Brains from Young Rats and
Mice. To study changes in MT localization with growth, brains from 1-3-week-old rats were used. In contrast to adult rat brain but in accordance with mouse brain, strong MT immunostaining was found in the ependymal cells of the ventricles (Figure 3a ), pia mater, and arachnoid ( Figure 3b ); weak MT staining was found in some glial cells in the parenchyma (Figure 3c ). In addition, strong MT immunostaining was found in some epithelial cells (cytoplasm and nucleus) of the choroid plexus ( Figure 3d ). No MT staining was found in neurons and endothelial cells in the parenchyma.
In the brains from 1-3-week-old mice, the MT immunostaining pattern was almost identical to that in adult mouse brains (Figure 2) .
Metallothionein Localization in Brains of Cd-treated Rats and Mice. When the antiserum was replaced with the one pre-absorbed with appropriate amounts of rat MT-2, almost no immunostaining was detected (Figure 4a ). On Cd treatment, strong MT immunostaining was observed in the cytoplasm, nucleus, and cilia of all the ependymal cells of the third (Figure 4b ) and lateral ( Figure  4c ) ventricles. The pia mater, arachnoid (Figure 4d ), and some glial cells (Figure 4e ), as well as their processes, exhibited immunostaining. Endothelial cells in the brain parenchyma were conspicuous for intense MT immunostaining (Figure 4f ). MT was not detected in the hippocampus and the choroid plexus (not shown).
When mice were injected with CdCl2, localization of MT was identical to that found in non-treated mice (Figure 2 ). except that MT was induced in the endothelial cells (not shown).
Metallothionein, Zinc, and Cadmium Concentrations in Brains of Mice and Rats. Concentrations of MT, Zn, and Cd in brains from adult mice and rats are summarized in Table 1 . The MT concentration of the adult mouse brain was significantly higher than that of control and Cd-treated rats. On the other hand, the Zn concentration in the mouse brain was found to be significantly lower than those of the control and Cd-treated rat brains. Negligible induction of MT by Cd treatment was probably due to minimal uptake of Cd into the brain parenchyma. Despite the strong MT immunostaining in specific cells, brains from neonatal rats (1-3 weeks of age) contained MT at a concentration of approximately 1.5 pglg tissue.
Discussion
The present results demonstrate localization of MT in specific cells. such as ependymal cells and choroid plexus epithelium, of the brains of rats and mice under physiological conditions as well as in Cdtreated rats. Ependymal cells, singly stratified cuboidal cells that cover the surface of the ventricles of the brain and the central canal of the spinal cord, are very active in cell proliferation in fetal and newborn rat but not in adult rat (Bruni et al., 1985) . These cells differentiate until a certain period after birth (Bruni et al., 1983; Roessmann et al., 1980; Walsh et al., 1978) . For example, ependymal cells of rat brain show many mitotic figures until 10 days after birth (Walsh et al.. 1978) . Recently it has been shown that MT is present in specific cells of developing rat liver and kidney (Nishimura et al., 1989b; Panemangalore et al., 1983) , regenerating rat liver (Tohyama et al., l989), female (Nishimura et al., 1989a) and male (Nishimura et al., 1990a) reproductive organs, as well as in mouse skin treated with tetradecanoyl phorbol ester, a potent promoter for mouse skin carcinogenesis (Karasawa et al., 1991) . The present study indicates also the presence of MT in the choroid plexus of developing stages of rats and mice but not in the adult animals. The appearance and disappearance of MT with age can be an indicator that reflects specific stages of development of these cells. MT may be associated with cell growth by a supply of Zn ions and/or by yet unidentified mechanisms. In addition, the presence of MT in the ependymal cells of adult mice but not of adult rats may be due to a species-related difference.
We failed to find a relationship between levels of tissue MTand Zn, which is consistent with recent observations in different areas of the rat brain (Hidalgo et al., 1991) . Although in their study MT was detected at the highest concentration in the hippocampus among the several areas of the brain, the lack of MT immunostaining in the present study may be explained by the possibility that immunostaining was less sensitive than radioimmunoassay, and/or that the Zn may be present as Zn ions bound to carbonic anhydrase (Klee and Lieflander, 1965; MacLardy, 1964) in addition to MT.
Radiolabeled Cd was found in an autoradiographical study to be taken up by limited areas of the brain, such as choroid plexus and meninges, in contrast to almost no accumulation of the metal 3 a in the parenchyma (Arvidson and Tjalve, 1986) . A similar observation also was obtained after mercuric chloride administration (Berlin and Ullberg, 1963b) . In the present study, Cd administration to rats and mice did not induce sufficient amounts of MT to be observable by immunohistochemical staining, in choroid plexus and meninges. The apparent discrepancy between the observations on the presence of Cd (Arvidson and Tjalve, 1986) and the absence (the present study) of MT in these areas may be explained by a lower level of exposure of the former (0.045 pg Cd/kg body weight) and a higher level of treatment of the latter (2 mg Cdlkg body weight). This would account for the lack of MT production due to possible injury to the choroidal epithelium in rats excessively exposed to Cd. This speculation is supported by the evidence that Cd administration at high doses (oral treatment at 10 and 100 ppm Cd for 22 weeks) resulted in degenerative changes and widening of gaps between epithelial cells of mouse brain, whereas a low dose of Cd (1 ppm for the same period) did not (Valois and Webster, 1989) .
It has been demonstrated that MT exists in areas endowed with barrier functions, such as areas adjacent to maternal blood vessels in the placental basal zone (Hazelhoff-Roelfzema et al., 1989) and epithelium of the pigment layer in the retina . Since capillaries of the brain are not fenestrated and are formed with well-developed tight occluding junctions between endothelial cells (Reese and Karnovsky, 1967) . they play a major role in the blood-brain barrier which protects the parenchyma against influx of various substances from the blood. The finding that Cd administration induced MT in the endothelial cells may be relevant to the function of the blood-brain barrier. Regarding a possible role of ependymal cells in handling toxic heavy metal ions, the possibility exists that the cells eliminate chemicals into the ventricle. Nevertheless, induction of MT was found in ependymal cells 4a -w'-. I only by direct injection of zinc ions into the third ventricle of the brain of Mongolian gerbils, supporting the hypothesis of direct uptake of zinc into the cells from the cerebrospinal fluid (Yoshimine et al., unpublished data). This observation is consistent with the findings on the uptake of peroxidase (Kobayashi et al., 1972) and luteinizing hormone-releasing hormone (Uemura et al., 1975) from the ventricles. In the pia mater, the pial cells, resting macrophages (Nabeshima et al., 1975) , may defend against the undesirable foreign substances present in the cerebrospinal fluid, since the cells have the capacity to store foreign substances, such as dye, introduced by a direct injection into the subarachnoid space (Bloom and Fawcett, 1986) . One of the roles of glial cells is believed to be phagocytosis of foreign substances, and induction of MT found in the glial cells on Cd treatment may be explained by uptake of Cd ions from cerebrospinal fluid or capillaries. In both the endothelial and ependymal cells, MT is considered to reduce toxicity of heavy metal ions by binding the metal ions in these cells. Strong immunostaining for MT in ependymal cells, arachnoid, pia mater, and glial cells also was observed in rats treated with inorganic mercury, organic mercury , and silver sulfadiazine (Nishimura et al., 1990b) . Although the toxicity of these metals is reduced by the well-developed barrier systems in the brain, induction of MT in these tissues also may play a detoxifying role in the barrier systems.
